Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Benzocaine Monograph For Toothache Requires Further Study – FDA

This article was originally published in The Tan Sheet

Executive Summary

FDA says benzocaine-containing oral analgesic manufacturers will have to conduct a larger clinical trial to support a Category I (safe and effective) classification for the treatment of toothaches
Advertisement

Related Content

Benzocaine study
Benzocaine study
Benzocaine study
Benzocaine Study Revisions Proposed; Trial Slated To Begin In Spring
Benzocaine Study Revisions Proposed; Trial Slated To Begin In Spring
Benzocaine Study Revisions Proposed; Trial Slated To Begin In Spring
OTC Firms Try Again For Benzocaine Monograph Status
Benzocaine Repeat-Dosing, Three-Arm Trials Recommended By FDA’s Ganley
Benzocaine Repeat-Dosing, Three-Arm Trials Recommended By FDA’s Ganley

Topics

Advertisement
UsernamePublicRestriction

Register

PS097005

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel